Takara Bio Dividends and Buybacks

Dividend criteria checks 2/6

Takara Bio is a dividend paying company with a current yield of 2.15%. Next payment date is on 25th June, 2025 with an ex-dividend date of 28th March, 2025.

Key information

2.2%

Dividend yield

n/a

Buyback Yield

Total Shareholder Yieldn/a
Future Dividend Yield3.4%
Dividend Growth25.0%
Next dividend pay date25 Jun 25
Ex dividend date28 Mar 25
Dividend per sharen/a
Payout ratio197%

Recent dividend and buyback updates

Recent updates

Some Investors May Be Willing To Look Past Takara Bio's (TSE:4974) Soft Earnings

May 22
Some Investors May Be Willing To Look Past Takara Bio's (TSE:4974) Soft Earnings

Takara Bio (TSE:4974) Has Announced A Dividend Of ¥17.00

Mar 12
Takara Bio (TSE:4974) Has Announced A Dividend Of ¥17.00

Takara Bio (TSE:4974) Has Announced A Dividend Of ¥17.00

Feb 18
Takara Bio (TSE:4974) Has Announced A Dividend Of ¥17.00

Earnings Update: Takara Bio Inc. (TSE:4974) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts

Feb 16
Earnings Update: Takara Bio Inc. (TSE:4974) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts

Takara Bio (TSE:4974) Has Affirmed Its Dividend Of ¥17.00

Jan 31
Takara Bio (TSE:4974) Has Affirmed Its Dividend Of ¥17.00

Takara Bio (TSE:4974) Is Paying Out A Dividend Of ¥17.00

Jan 17
Takara Bio (TSE:4974) Is Paying Out A Dividend Of ¥17.00

Some May Be Optimistic About Takara Bio's (TSE:4974) Earnings

Nov 20
Some May Be Optimistic About Takara Bio's (TSE:4974) Earnings

Takara Bio (TSE:4974) Is Paying Out A Dividend Of ¥17.00

Nov 11
Takara Bio (TSE:4974) Is Paying Out A Dividend Of ¥17.00

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: 4974's dividend payments have been volatile in the past 10 years.

Growing Dividend: 4974's dividend payments have increased over the past 10 years.


Dividend Yield vs Market

Takara Bio Dividend Yield vs Market
How does 4974 dividend yield compare to the market?
SegmentDividend Yield
Company (4974)2.2%
Market Bottom 25% (JP)1.9%
Market Top 25% (JP)4.0%
Industry Average (Biotechs)1.2%
Analyst forecast (4974) (up to 3 years)3.4%

Notable Dividend: 4974's dividend (2.15%) is higher than the bottom 25% of dividend payers in the JP market (1.89%).

High Dividend: 4974's dividend (2.15%) is low compared to the top 25% of dividend payers in the JP market (4.01%).


Earnings Payout to Shareholders

Earnings Coverage: With its high payout ratio (196.6%), 4974's dividend payments are not well covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: 4974 is paying a dividend but the company has no free cash flows.


Discover strong dividend paying companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/28 08:15
End of Day Share Price 2025/05/28 00:00
Earnings2025/03/31
Annual Earnings2025/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Takara Bio Inc. is covered by 8 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hidemaru YamaguchiCitigroup Inc
Yen Ting ChenCredit Suisse
Kiyokazu YamazakiIchiyoshi Research Institute Inc.